By Sujata Gupta Anne-Laure Le Cunff was something of a wild child. As a teenager, she repeatedly disabled the school fire alarm to sneak smoke breaks and helped launch a magazine filled with her teachers’ fictional love lives. Later, as a young adult studying neuroscience, Le Cunff would spend hours researching complex topics but struggled to complete simple administrative tasks. And she often obsessed over random projects before abruptly abandoning them. Then, three years ago, a colleague asked Le Cunff if she might have attention-deficit/hyperactivity disorder, or ADHD, a condition marked by distractibility, hyperactivity and impulsivity. Doctors confirmed her colleague’s suspicions. But fearing professional stigma, Le Cunff — by then by then a postdoctoral fellow in the ADHD Lab at King’s College London — kept her diagnosis secret until this year. Le Cunff knew all too well about the deficits associated with ADHD. But her research — and personal experience — hinted at an underappreciated upside. “I started seeing … breadcrumbs pointing at a potential association between curiosity and ADHD,” she says. People within the ADHD community have long recognized that the condition can be both harmful and helpful. Researchers, though, have largely focused on the harms. And those studying treatments tend to define success as a reduction in ADHD symptoms, with little regard to possible benefits. That’s starting to change. For instance, Norwegian researchers asked 50 individuals with ADHD to describe their positive experiences with the disorder as part of an effort to develop more holistic treatments. People cited their creativity, energy, adaptability, resilience and curiosity, researchers reported in BMJ Open in October 2023. © Society for Science & the Public 2000–2025.

Keyword: ADHD; Attention
Link ID: 29932 - Posted: 09.17.2025

Rachel Fieldhouse Deep in the rainforests of the Democratic Republic of the Congo, Mélissa Berthet found bonobos doing something thought to be uniquely human. During the six months that Berthet observed the primates, they combined calls in several ways to make complex phrases1. In one example, bonobos (Pan paniscus) that were building nests together added a yelp, meaning ‘let’s do this’, to a grunt that says ‘look at me’. “It’s really a way to say: ‘Look at what I’m doing, and let’s do this all together’,” says Berthet, who studies primates and linguistics at the University of Rennes, France. In another case, a peep that means ‘I would like to do this’ was followed by a whistle signalling ‘let’s stay together’. The bonobos combine the two calls in sensitive social contexts, says Berthet. “I think it’s to bring peace.” The study, reported in April, is one of several examples from the past few years that highlight just how sophisticated vocal communication in non-human animals can be. In some species of primate, whale2 and bird, researchers have identified features and patterns of vocalization that have long been considered defining characteristics of human language. These results challenge ideas about what makes human language special — and even how ‘language’ should be defined. Perhaps unsurprisingly, many scientists turn to artificial intelligence (AI) tools to speed up the detection and interpretation of animal sounds, and to probe aspects of communication that human listeners might miss. “It’s doing something that just wasn’t possible through traditional means,” says David Robinson, an AI researcher at the Earth Species Project, a non-profit organization based in Berkeley, California, that is developing AI systems to decode communication across the animal kingdom. As the research advances, there is increasing interest in using AI tools not only to listen in on animal speech, but also to potentially talk back. © 2025 Springer Nature Limited

Keyword: Animal Communication; Language
Link ID: 29931 - Posted: 09.17.2025

Andrew Gregory Health editor A daily pill for weight loss can help people reduce their body weight by as much as a fifth, according to a trial that could pave the way for millions more people to shed pounds. The drug, called orforglipron, is manufactured by Eli Lilly and targets the same GLP-1 receptors as weight loss injections such as Mounjaro and Wegovy. In a trial of 3,127 adults, one in five people who took the once-a-day tablet for 72 weeks lost 20% or more of their body weight. Weight loss jabs have been transformative but pill versions are seen as a holy grail because they are easier to store, distribute and administer and are also expected to be cheaper, offering fresh hope for the millions of people trying to lose weight. Orforglipron is a GLP-1 agonist, a type of medication that helps lower blood sugar levels, slows the digestion of food and can reduce appetite. The weight loss seen among people taking the tablet is not as stark as that among patients taking tirzepatide (Mounjaro), which is also made by Eli Lilly, but experts believe the tablet will be more accessible and convenient compared with injections. Orforglipron is not yet approved by the US Food and Drug Administration (FDA) or regulators in other countries. Eli Lilly has said it expects substantial demand when the new pill is launched. The company published a snapshot of the results in August and the full paper detailing the findings has now been published in the New England Journal of Medicine and presented to the annual meeting of the European Association for the Study of Diabetes in Vienna, Austria. © 2025 Guardian News & Media Limited

Keyword: Obesity
Link ID: 29930 - Posted: 09.17.2025

Nic Fleming In the early 2000s, Brazilian nutrition researcher Carlos Monteiro made a puzzling discovery that led to an epiphany. While trawling survey data on household spending to try to understand why rates of obesity and type 2 diabetes were rising so rapidly in his home country, he was surprised to note that people were buying smaller quantities of sugar, salt and other ingredients generally associated with these conditions than they had in previous decades. Only when Monteiro and his colleagues dug deeper did they find the culprit. People were buying less sugar to prepare cakes and desserts, but eating more of it in pre-made pastries and breakfast cereal. They were buying less salt, but consuming more of it in frozen pizzas, chicken nuggets and dehydrated packet soups. “We realized the problem was our traditional dietary patterns were being replaced by foods that are processed so many times that they can no longer be recognized in the final products. We called them ultra-processed foods.” Monteiro, a nutrition and public-health researcher at the University of São Paulo, first used the term ultra-processed food (UPF) in a paper in 2009, arguing that people interested in promoting healthy diets should focus more on the degree, extent and purpose of processing than on nutrient profiles1. It was a radical idea that caught the attention of other researchers, who, over the next decade or so, published dozens of papers linking UPFs with obesity and a range of other health problems. Governments took notice, too. In 2014, Brazil began advising people to avoid UPFs. Other countries, including France, Belgium and Israel, followed suit. Robert F. Kennedy Jr, secretary of the US Department of Health and Human Services (HHS), has been a critic of UPFs, saying in January that they are “poisoning the American people”. In May, the US government announced plans for a research agenda to support nutrition policy and improve people’s diets, in part by improving understanding of the impacts of UPFs on health. © 2025 Springer Nature Limited

Keyword: Obesity
Link ID: 29929 - Posted: 09.17.2025

By Claudia López Lloreda Mouse pups, like other infants across the animal kingdom, cry to get their mother’s attention. The oxytocin system drives this communication and shapes how baby mice interact when reunited with their mothers, according to a study out today in Science. Oxytocin, known colloquially as the “love” or “cuddle” hormone, stimulates milk release during nursing and promotes maternal care behaviors. But most oxytocin research thus far has focused solely on the mother, overlooking the neuropeptide’s potential effects on an infant’s brain and behavior. This new study shows “the other half of the equation to what we already knew,” says Zoe Donaldson, associate professor of behavioral neuroscience at the University of Colorado Boulder, who was not involved with the study. Oxytocin is “this social signal that ultimately reinforces relationships,” she says. The work employed a novel optogenetic tool that enabled the team to turn off neurons deep in the hypothalamus of mouse pups. After being separated from their mothers for three hours, the pups vocalized more using distinct patterns when reunited with their mothers than did pups that had not been separated, a process controlled by oxytocin neurons in the pups’ hypothalamus, the team found. “It would make sense if oxytocin is on both sides of this: making moms want to take care of their pups that are calling, and making pups call in a manner that makes mom want to take care of them,” Donaldson says. “Then we have this sort of convergence where oxytocin is once again doing everything.” © 2025 Simons Foundation

Keyword: Sexual Behavior; Animal Communication
Link ID: 29928 - Posted: 09.13.2025

By Andrea Thompson A school-aged child in Los Angeles County has died from a rare but always fatal complication from a measles infection they acquired when they were an infant who was too young to be vaccinated. The first dose of the vaccine is typically not administered until one year of age. Experts say the death underscores the need for high levels of vaccination in a population to protect the most vulnerable against the disease, as well as from side effects that can occur long after the initial illness has passed. “This case is a painful reminder of how dangerous measles can be, especially for our most vulnerable community members,” said Los Angeles County Health Officer Muntu Davis in a recent statement. The child who died suffered from subacute sclerosing panencephalitis (SSPE), a progressive brain disorder that usually develops two to 10 years after a measles infection. The measles virus appears to mutate into a form that avoids detection by the immune system, allowing it to hide in the brain and eventually destroy neurons. “It’s just a virus that goes unchecked and destroys brain tissue, and we have no therapy for it,” said Walter Orenstein, an epidemiologist and professor emeritus at Emory University, to Scientific American earlier this year. People with SSPE experience a gradual, worsening loss of neurological function and usually die within one to three years after diagnosis, according to the Los Angeles County Health Department. The disorder affects only about one in every 10,000 people who contract measles. But the risk may be as high as about one in 600 for those who are infected as infants. “There is no treatment for this. Children who suffer from this will always die,” said Paul Offit, director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia, in a previous interview with Scientific American. © 2025 SCIENTIFIC AMERICAN,

Keyword: Development of the Brain
Link ID: 29927 - Posted: 09.13.2025

By Jake Buehler All eight arms of an octopus can be used for whatever their cephalopod owner wishes, but some arms are favored for certain tasks. A new, detailed analysis of how octopuses wield their famously flexible appendages suggests that all eight arms share a skill set, but the front four spend more time on exploration and the back four on movement. The findings, published September 11 in Scientific Reports, provide a comprehensive accounting of how subtle arm movements coordinate the clever invertebrates’ repertoire of behaviors. Octopuses live their lives through their sucker-lined arms, which make up the bulk of their body mass and contain most of their nervous system. Marine biologist Chelsea Bennice wanted to understand how octopuses use the extreme flexibility of their boneless limbs to move, hunt and investigate their environment. Her colleagues had examined some of these behaviors in laboratory settings, but not in the wild. Bennice and her colleagues watched 25 videos, filmed from 2007 to 2015, of multiple species of wild octopuses in Spain and the Caribbean, cataloging their behaviors and arm movements. In all, the researchers logged nearly 4,000 arm actions, which could be broken down into 12 types, including raising, reaching and grasping. The arms could deform in four distinct ways: elongating, shortening, bending and twisting. The team found that the octopuses were exceptionally ambidextrous. “Octopuses are ultimate multitaskers,” says Bennice, of Florida Atlantic University in Boca Raton. “All arms are capable of all arm behaviors and all arm deformations. They can even use multiple arm actions on a single arm and on several arms at the same time.” © Society for Science & the Public 2000–2025.

Keyword: Laterality; Evolution
Link ID: 29926 - Posted: 09.13.2025

By Kenneth Chang After decades of brain research, scientists still aren’t sure whether most people see the same way, more or less — especially with colors. Is what I call red also red for you? Or could my red be your blue? Or maybe neon pink? If it were possible to project what I see directly into your mind, would the view be the same, or would it instead resemble a crazy-hued Andy Warhol painting? “That’s an age-old question, isn’t it?” said Andreas Bartels, a professor of visual neuroscience at the University of Tübingen in Germany. But scientists do have a good understanding of which parts of the brain handle vision. They have even figured out where various vision-processing tasks are performed, like recognizing what is moving, identifying colors and adjusting to different lighting conditions. Amazingly, it is even possible to deduce what you’re seeing by looking at an M.R.I. scan showing which parts of your brain are lighting up. “That comes out of the world of science fiction, or one would think, right?” Dr. Bartels said. “It’s amazing that this is possible, but this always has happened in individual brains.” That is, researchers pulled off this sleight of science with individuals. They would first show a subject lying in the M.R.I. machine a series of images, mapping out how that person’s brain responded. After that initial training, the researchers could randomly show one of the images and, based on just the brain activity, make a good guess at what the image was. In new research, Dr. Bartels and Michael Bannert, a postdoctoral researcher in Dr. Bartels’ laboratory, used that technique to provide a partial answer to the question of whether most of us have a shared sense of colors. They put 15 people, all with standard color vision, in an M.R.I. machine. The volunteers viewed expanding concentric rings that were red, green or yellow. © 2025 The New York Times Company

Keyword: Vision; Consciousness
Link ID: 29925 - Posted: 09.10.2025

Ian Sample Science editor The cry of a distressed baby triggers a rapid emotional response in both men and women that is enough to make them physically hotter, researchers say. Thermal imaging revealed that people experienced a rush of blood to the face that raised the temperature of their skin when they were played recordings of babies wailing. The effect was stronger and more synchronised when babies were more distressed, leading them to produce more chaotic and disharmonious cries. The work suggests that humans respond automatically to specific features in cries that ramp up when babies are in pain. “The emotional response to cries depends on their ‘acoustic roughness’,” said Prof Nicolas Mathevon at the University of Saint-Etienne in France. “We are emotionally sensitive to the acoustic parameters that encode the level of pain in a baby’s cry.” Evolution equipped baby humans with a hard-to-ignore wail to boost their odds of getting the care they need. But not all infant cries are the same. When a baby is in real distress, they forcefully contract their rib cage, producing higher pressure air that causes chaotic vibrations in the vocal cords. This produces “acoustic roughness”, or more technically, disharmonious sounds called nonlinear phenomena (NLP). To see how men and women responded to infants’ cries, scientists played recordings to volunteers with little or no experience with babies. While listening, the participants were filmed with a thermal camera that captured subtle changes in their facial temperature. © 2025 Guardian News & Media Limited

Keyword: Sexual Behavior; Emotions
Link ID: 29924 - Posted: 09.10.2025

By Viviane Callier All animals, from jellyfish to humans, need sleep. But how these wide-ranging organisms control that need has remained a mystery. It turns out that—in fruit flies, at least—sleep might be an “inescapable consequence” of aerobic metabolism, according to a new study. Mitochondria in Drosophila’s sleep-regulating neurons sense metabolic damage that accumulates during waking hours and trigger the pressure to sleep. “It’s a really beautiful contribution,” says Keith Hengen, associate professor of biology at Washington University in St. Louis, who was not involved in the work. The study explains how the brain integrates information from a metabolic thermostat to regulate sleep pressure, Hengen says. “That’s a really hard problem, and I think they’ve nailed it.” The regulators of sleep are distinct from the function of sleep, Hengen and other sleep researchers note. Just as fullness regulates food intake, but food intake doesn’t so much serve to fill the stomach as to get calories and nutrients, “we need to make this distinction between sensing of sleep pressure and the function of sleep,” says Giorgio Gilestro, associate professor of systems neurobiology at Imperial College London, who was not involved in the new study. And with respect to sleep pressure, he adds, there are two processes at play: a well-studied circadian clock mechanism that links sleep to daylight cycles, and a less-understood homeostatic process that fine-tunes the need for sleep based on other factors. © 2025 Simons Foundation

Keyword: Sleep; Evolution
Link ID: 29923 - Posted: 09.10.2025

By Sofia Caetano Avritzer When Canada legalized cannabis in 2018, its effects on human health were all over the news. Cyntia Duval, a women’s health researcher at the University of Toronto at the time, wondered how its consumption might affect female fertility. To her surprise, there was almost no information on the subject — though there was plenty of data on marijuana’s effects on pregnancy and male fertility. Chemicals in cannabis may push eggs to become ready for fertilization. But this may come at a cost: more eggs with the wrong number of chromosomes, Duval and colleagues now report in a study published September 9 in Nature Communications. Delta-9-tetrahydrocannabinol, or THC, is the main psychoactive chemical in marijuana. It binds to cannabinoid receptors in the brain. But these receptors are all over our bodies, including in our reproductive organs. The receptors usually bind endocannabinoids, molecules naturally produced by the body and essential for normal bodily functions like the production of eggs and sperm. Consuming THC can affect cannabinoid receptors in the reproductive system. Many studies report that using cannabis decreases sperm count and motility. Men are usually told to avoid cannabis for at least three months before trying to conceive, Duval says. But what about women? © Society for Science & the Public 2000–2025.

Keyword: Drug Abuse; Sexual Behavior
Link ID: 29922 - Posted: 09.10.2025

By Rachel E. Gross The first thing Debra McVean did when she woke up at the hospital in March 2024 was try to get to the bathroom. But her left arm wouldn’t move; neither would her left leg. She was paralyzed all along her left side. She had suffered a stroke, her doctor soon explained. A few nights before, a blood clot had lodged in an artery in her neck, choking off oxygen to her brain cells. Now an M.R.I. showed a dark spot in her brain, an eerie absence directly behind her right eye. What that meant for her prognosis, however, the doctor couldn’t say. “Something’s missing there, but you don’t know what,” Ms. McVean’s husband, Ian, recalled recently. “And you don’t know how that will affect her recovery. It’s that uncertainty, it eats away at you.” With a brain injury, unlike a broken bone, there is no clear road to recovery. Nor are there medical tools or therapies to help guide the brain toward healing. All doctors can do is encourage patients to work hard in rehab, and hope. That is why, for decades, the medical attitude toward survivors of brain injury has been largely one of neurological “nihilism,” said Dr. Fernando Testai, a neurologist at the University of Illinois, Chicago, and the editor in chief of the Journal of Stroke and Cerebrovascular Diseases. Stroke, he said, “was often seen as a disease of ‘diagnose and adios.’” That may be about to change. A few days after Ms. McVean woke up in the Foothills Medical Center in Calgary, she was told about a clinical trial for a pill that could help the brain recover from a stroke or traumatic injury, called Maraviroc. Given her level of physical disability, she was a good candidate for the study. She hesitated. The pills were large — horse pills, she called them. But she knew the study could help others, and there was a 50 percent chance that she would get a drug that could help her, too. © 2025 The New York Times Company

Keyword: Stroke; Regeneration
Link ID: 29921 - Posted: 09.06.2025

Rachel Fieldhouse An analysis of 56 million people has shown that exposure to air pollution increases the risk of developing a particular form of dementia, the third most common type after Alzheimer’s disease and vascular dementia. The study, published in Science on 4 September1, suggests that there is a clear link between long-term exposure to PM2.5 — airborne particles that are smaller than 2.5 micrometres in diameter — and the development of dementia in people with Lewy body dementia or Parkinson’s disease. The study found that PM2.5 exposure does not necessarily induce Lewy body dementia, but “accelerates the development,” in people who are already genetically predisposed to it, says Hui Chen, a clinician–neuroscientist at the University of Technology Sydney in Australia. PM2.5 exposure Lewy body dementia is an umbrella term for two different types of dementia: Parkinson’s disease with dementia, and dementia with Lewy bodies. In both cases, dementia is caused by the build-up of α-synuclein (αSyn) proteins into clumps, called Lewy bodies, in the brain’s nerve cells, which cause the cells to stop working and eventually die. Studies have suggested that long-term exposure to air pollution from car-exhaust, wildfires and factory fumes, is linked with increased risks of developing neurodegenerative illnesses, including Parkinson's disease with dementia2. Study co-author Xiaobo Mao, who researches neurodegenerative conditions at Johns Hopkins University in Baltimore, Maryland, says he and his colleagues wanted to determine if PM2.5 exposure also influenced the risk of developing Lewy body dementia. They analysed 2000–2014 hospital-admissions data from 56.5 million people with Lewy body dementia and Parkinson’s disease with or without dementia. The data served to identify people with severe neurological diseases. © 2025 Springer Nature Limited

Keyword: Alzheimers; Parkinsons
Link ID: 29920 - Posted: 09.06.2025

Ivana Drobnjak O'Brien An ultrasound “helmet” offers potential new ways for treating neurological conditions without surgery or other invasive procedures, a study has shown. The device can target brain regions 1,000 times smaller than ultrasound can, and could replace existing approaches such as deep brain stimulation (DBS) in treating Parkinson’s disease. It also holds potential for conditions such as depression, Tourette syndrome, chronic pain, Alzheimer’s and addiction. Unlike DBS, which requires a highly invasive procedure in which electrodes are implanted deep in the brain to deliver electrical pulses, using ultrasound sends mechanical pulses into the brain. But no one had managed to create an approach capable of delivering them precisely enough to make a meaningful impact until now. A study published in Nature Communications introduces a breakthrough system that can hit brain regions 30 times smaller than previous deep-brain ultrasound devices could. “It is a head helmet with 256 sources that fits inside an MRI scanner,” said the author and participant Ioana Grigoras, of Oxford University. “It is chunky and claustrophobic putting it on the head at first, but then you get comfortable.” Current DBS methods used on Parkinson’s patients use hard metal frames that are screwed into the head to hold them down. To test the system, the researchers applied it to seven volunteers, directing ultrasound waves to a tiny region the size of a grain of rice in the lateral geniculate nucleus (LGN), the key pathway for visual information that comes from the eyes to the brain. “The waves reached their target with remarkable accuracy,” the senior author Prof Charlotte Stagg of Oxford University said. “That alone was extraordinary, and no one has done it before.” Follow-up experiments showed that modulating the LGN produced lasting effects in the visual cortex, reducing its activity. “The equivalent in patients with Parkinson’s would be targeting a motor control region and seeing tremors disappear,” she added. © 2025 Guardian News & Media Limite

Keyword: Parkinsons; Brain imaging
Link ID: 29919 - Posted: 09.06.2025

By Claudia López Lloreda The process of making a decision engages neurons across the entire brain, according to a new mouse dataset created by an international collaboration. “Many, many areas are recruited even for what are arguably rather simple decisions,” says Anne Churchland, professor of neurobiology at University of California, Los Angeles and one of the founding members of the collaboration, called the International Brain Laboratory (IBL). The canonical model suggests that the activity underlying vision-dependent decisions goes from the visual thalamus to the primary visual cortex and association areas, and then possibly to the frontal cortex, Churchland says. But the new findings suggest that “maybe there’s more parallel processing and less of a straightforward circuit than we thought.” Churchland and other scientists established the IBL in 2017 out of frustration with small-scale studies of decision-making that analyzed only one or two brain regions at a time. The IBL aimed to study how the brain integrates information and makes a decision at scale. “We came together as a large group with the realization that a large team effort could be transformative in these questions that had been kind of stymieing all of us,” Churchland says. After years of standardizing their methods and instrumentation across the 12 participating labs, the IBL team constructed a brain-wide map of neural activity in mice as they complete a decision-making task. That map, published today in Nature, reveals that the activity associated with choices and motor actions shows up widely across the brain. The same is true for the activity underlying decisions based on prior knowledge, according to a companion paper by the same team, also published today in Nature. © 2025 Simons Foundation

Keyword: Attention; Brain imaging
Link ID: 29918 - Posted: 09.06.2025

Jon Hamilton A rigorous new study finds that a single dose of LSD can ease anxiety and depression for months. The study involved 198 adults with generalized anxiety disorder, or GAD, a disabling form of anxiety that affects about 1 in 10 people over the course of a year. Participants who got lower doses of LSD (25 or 50 micrograms) did no better than those who got a placebo. But people who received higher doses (100 or 200 micrograms) responded quickly, a team reports in the Journal of the American Medical Association. "By the next day, they were showing strong improvements," says Dr. David Feifel of Kadima Neuropsychiatry Institute in San Diego, one of the 22 centers that participated in the study. "And those improvements held out all the way to the end of the study, which was 12 weeks." But it's unclear whether some of the improvement was related to non-drug factors like the sensory environment in which people were treated, says Robin Carhart-Harris, a psychedelics researcher at the University of California, San Francisco who was not involved in the study. "The safety looks good, the tolerability looks good," he says, "but where is the depth of information about the way you delivered this product?" Carhart-Harris, like many scientists who study psychedelics, believes that successful treatment is more likely if a person has the right mindset when beginning a trip and if the trip occurs in a place with the right sensory environment. "It's characterized by continuous worry, inability to relax, and all the physical manifestations, racing heart rates and sweatiness," Feifel says. It's also frequently accompanied by depression. Current antidepressant and antianxiety drugs are inadequate for about half of people diagnosed with GAD. © 2025 npr

Keyword: Stress; Drug Abuse
Link ID: 29917 - Posted: 09.06.2025

By Ute Eberle Before weight coach Bella Barnes consults with new clients, she already knows what they’ll say. The women struggle with their weight, naturally. But they don’t want to lose pounds. They want to gain them. Her clients find themselves too thin, and they’re suffering. “Last week, I signed up a client who wears leggings that have bum pads in them,” says Barnes, who lives in Great Britain. “I’ve had another client recently that, in summer, wears three pairs of leggings just to try and make herself look a bit bigger.” These women belong to a demographic group that has been widely overlooked. As the world focuses on its billion-plus obese citizens, there remain people at the other end of the spectrum who are skinny, often painfully so, but don’t want to be. Researchers estimate that around 1.9 percent of the population are “constitutionally thin,” with 6.5 million of these people in the United States alone. YOU MAY ALSO LIKE Conceptual illustration shows three dinner plates, two at night with crescent moons are empty, representing a nightly fast, and a third with a sun theme, full of food and representing the benefits of eating during a limited time during the day. Constitutionally thin individuals often eat as much as their peers and don’t exercise hard. Yet their body mass index is below 18.5 — and sometimes as low as 14, which translates to 72 pounds on a five-foot frame — and they don’t easily gain weight. The condition is “a real enigma,” write the authors of a recent paper in the Annual Review of Nutrition. Constitutional thinness, they say, challenges “basic dogmatic knowledge about energy balance and metabolism.” It is also understudied: Fewer than 50 clinical studies have looked at constitutionally thin people, compared with thousands on unwanted weight gain. © 2025 Annual Reviews

Keyword: Obesity
Link ID: 29916 - Posted: 09.06.2025

By Jeré Longman Dr. A. James Hudspeth, a neuroscientist at the Rockefeller University in Manhattan who was pivotal in discovering how sound waves are converted in the inner ear to electrical signals that the brain can perceive as a whisper, a symphony or a thunderclap, died on Aug. 16 at his home in Manhattan. He was 79. His wife, Dr. Ann Maurine Packard, said the cause was glioblastoma, a brain cancer. Scientists have long understood how sound waves enter the ear canal and cause the eardrum to vibrate. They have also understood how the vibrations travel through the three small bones of the middle ear, then to the cochlea in the inner ear, a tiny organ about the size of a chickpea that is filled with fluid and is shaped like a snail’s shell. And they have long known that microscopic receptor cells in the cochlea play a role in the process of hearing. But by the time Dr. Hudspeth began his research in the 1970s, it was still unclear how these cells — known as hair cells (the name derives from tufts of cylindrical, hairlike rods known as stereocilia) — transformed the mechanical vibrations of sound waves into nerve impulses that the brain could interpret as, say, a child crying or a dog barking. Dr. Hudspeth “provided the major framework” for this understanding, the committee that awarded him and two other scientists (Robert Fettiplace and Christine Petit) the Kavli Prize in Neuroscience for their pioneering work on the processes of hearing wrote in its citation in 2018. Each cochlea contains about 16,000 hair cells. Atop each cell, 20 to 300 of these rods are gathered in a bundle — the shortest to the tallest — in rows that resemble a staircase or a pipe organ. Hair cells line the cochlea, with each tuned to a narrow frequency range that collectively decodes the broad spectrum of tones in every sound. © 2025 The New York Times Compan

Keyword: Hearing
Link ID: 29915 - Posted: 09.06.2025

Ian Sample Science editor A three-minute brainwave test can detect memory problems linked to Alzheimer’s disease long before people are typically diagnosed, raising hopes that the approach could help identify those most likely to benefit from new drugs for the condition. In a small trial, the test flagged specific memory issues in people with mild cognitive impairment, highlighting who was at greater risk of developing Alzheimer’s. Trials in larger groups are under way. The Fastball test is a form of electroencephalogram (EEG) that uses small sensors on the scalp to record the brain’s electrical activity while people watch a stream of images on a screen. The test detects memory problems by analysing the brain’s automatic responses to images the person sees before the test. “This shows us that our new passive measure of memory, which we’ve built specifically for Alzheimer’s disease diagnosis, can be sensitive to those individuals at very high risk but who are not yet diagnosed,” said Dr George Stothart, a cognitive neuroscientist at the University of Bath, where the test was developed. The trial, run with the University of Bristol, involved 54 healthy adults and 52 patients with mild cognitive impairment (MCI). People with MCI have problems with memory, thinking or language, but these are not usually severe enough to prevent them doing their daily activities. Before the test, volunteers were shown eight images and told to name them, but not specifically to remember them or look out for them in the test. The researchers then recorded the participants’ brain activity as they watched hundreds of images flash up on a screen. Each image appeared for a third of a second and every fifth picture was one of the eight they had seen before. © 2025 Guardian News & Media Limited

Keyword: Alzheimers; Attention
Link ID: 29914 - Posted: 09.03.2025

Jon Hamilton People who inherit two copies of a gene variant called APOE4 have a 60% chance of developing Alzheimer's by age 85. Only about 2% to 3% of people in the U.S. have this genetic profile, and most of them don't know it because they've never sought genetic testing. But three scientists are among those who did get tested, and learned that they are in the high-risk group. Now, each is making an effort to protect not only their own brain, but the brains of others with the genotype known as APOE4-4. "I just felt like the end of the world," says June, who asked to use only her first name out of fear that making her genetic status public could affect her job or health insurance. June was 57 when she found out. As someone with a doctorate in biochemistry, she quickly understood what the results meant. New tests of blood and spinal fluid could help doctors quickly identify patients who would most benefit from treatment. "People with our genotype are almost destined to get the disease," she says. "We tend to get symptoms 7 to 10 years earlier than the general population, which means that I had about seven years left before I may get the disease." At first, June spent sleepless nights online, reading academic papers about Alzheimer's and genetics. She even looked into physician-assisted suicide in an effort to make sure she would not become a burden to her adult son. © 2025 npr

Keyword: Alzheimers; Genes & Behavior
Link ID: 29913 - Posted: 09.03.2025